Wellington Management Group’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Wellington Management Group’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-232,267	Closed	-$1M	–	2207
2022 Q2	$1M	Sell	232,267 -309,187	-57%	-$1.76M	﹤0.01%	1680
2022 Q1	$6.3M	Sell	541,454 -129,666	-19%	-$1.54M	﹤0.01%	1328
2021 Q4	$12.3M	Buy	671,120 +76,809	+13%	+$974K	﹤0.01%	1200
2021 Q3	$7.04M	Sell	594,311 -1,811,106	-75%	-$26.4M	﹤0.01%	1399
2021 Q2	$41.3M	Buy	2,405,417 +171,919	+8%	+$3.27M	0.01%	876
2021 Q1	$40.8M	Buy	2,233,498 +731,953	+49%	+$15.3M	0.01%	863
2020 Q4	$28.3M	Buy	1,501,545 +74,574	+5%	+$1.61M	0.01%	955
2020 Q3	$30.1M	Sell	1,426,971 -516,970	-27%	-$12.1M	0.01%	848
2020 Q2	$56.1M	Buy	1,943,941 +1,338,717	+221%	+$40.3M	0.01%	672
2020 Q1	$21.2M	Buy	605,224 +132,621	+28%	+$4.29M	0.01%	864
2019 Q4	$11.6M	Buy	+472,603	New	+$8.29M	﹤0.01%	1133

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.08B AUM 70.88% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group's OYST Position: Q3 2022 in Review

Wellington Management Group sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q3 2022, closing a stake of 232,267 shares — an estimated $1M sold.

Wellington Management Group first reported a position in OYST in Q4 2019 and held it in 11 quarters. The position peaked at $56.1M in Q2 2020. 60 funds tracked by Wall St. Rank hold OYST as of Q3 2022.

Wellington Management Group reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Wellington Management Group sold 232,267 Oyster Point Pharma, Inc. Common Stock shares in Q3 2022, an estimated $1M.
Wellington Management Group first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 11 quarters.
Wellington Management Group's Oyster Point Pharma, Inc. Common Stock position peaked at $56.1M in Q2 2020.
60 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q3 2022.

Based on Wellington Management Group's 13F filing for Q3 2022, filed 14 Nov 2022.